HE homepage

BioVentrix's Revivent system

The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.

Flu Shot

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

Federal Trade Comission FTC Sign logo

A U.S. District Court in Texas ruled that the agency overstepped its regulatory authority in passing the 2024 Biden-era reporting requirement, which would require stakeholders to spend more than 100 hours filling out a long form to give the agency more oversight of transactions. 

Ambulance emergency trauma

EMS colleagues with many years on the job but not much direct trauma exposure set the stage for suboptimal patient outcomes.

Michael Honigberg, MD, MPP, a preventive cardiologist and cardiovascular researcher at Massachusetts General Hospital, explains how preeclampsia and gestational hypertension during pregnancy can elevate cardiovascular risks later in life and how to best manage these patients.

Emerging research suggests that the early postpartum period may represent a critical window for influencing a woman's long-term cardiovascular health. 

Defiant nurse

Nurses are struggling to accept workplace assistance from AI. Not all, of course, but enough of them that those who appear to be resisting the relentless march of progress catch the public’s eye. 

Around the web

Many experts still recommend SAVR over TAVR for patients younger than 65 years old with severe aortic stenosis. However, transcatheter treatments are growing more and more popular when these younger patients require a valve replacement.